Quick Summary James Lind’s 18th-century shipboard experiment is a landmark moment in the history of clinical research, demonstrating how controlled comparisons can reveal effective treatments. We reimagined his study with a modern protocol title and criteria, then connected his work to the professionals who advance…
Quick Summary Ancillary supplies have always been part of clinical trial planning, but they haven’t always received the level of attention they deserve. Increasingly, sponsors, CROs, and clinical supply teams are recognizing how much non‑drug materials, everything from equipment to kitted supplies, can influence timelines,…
Clinical studies follow established timelines, and the work of preparing site and participant materials typically begins at a predictable point in that process. Most study teams assume writing begins only after the protocol is approved, and often don’t consider alternatives. Naturally, the best time to…
Much of life is rooted in communication, and this is certainly true in clinical research. Every study interaction, whether in person or through participant clinical trial materials, depends on clear and reliable information. When we communicate with participants, we convey essential details and set expectations.…
Risk management in clinical trials depends on systems that detect issues, correct them, and prevent them from returning. Corrective and Preventive Actions (CAPAs) are the structured process used to investigate deviations, address root causes, and strengthen controls. When CAPAs work, they protect study integrity and…